Search research articles
Contact Us
Filters
Showing results (371-380 of 759) with videos related to
Page
of 76
Sort By:
Journal of the National Cancer Institute
|
April 5, 2014
Multiple myeloma in the very old: an IASIA conference report
Sascha A Tuchman, Gary R Shapiro, William B Ershler, et al.
Blood
|
October 19, 2007
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
Angela Dispenzieri, Robert A Kyle, Jerry A Katzmann, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
February 26, 2017
Cardiac MR elastography for quantitative assessment of elevated myocardial stiffness in cardiac amyloidosis
Arvin Arani, Shivaram P Arunachalam, Ian C Y Chang, et al.
Bone Marrow Transplantation
|
November 19, 2020
Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis
Iuliana Vaxman, M Hasib Sidiqi, Abdullah S Al Saleh, et al.
Leukemia
|
June 25, 2021
A randomized phase 3 study of ixazomib-dexamethasone versus physician's choice in relapsed or refractory AL amyloidosis
Angela Dispenzieri, Efstathios Kastritis, Ashutosh D Wechalekar, et al.
Human Pathology
|
October 16, 2025
Dual amyloidosis: A clinicopathologic and proteomic analysis of 111 patients
Joanna C Dalland, Surendra Dasari, Jason D Theis, et al.
Blood Cancer Journal
|
May 13, 2020
Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)
Brian G M Durie, Antje Hoering, Rachael Sexton, et al.
ESC Heart Failure
|
August 31, 2024
Predictors of mortality by an artificial intelligence enhanced electrocardiogram model for cardiac amyloidosis
Jennifer M Amadio, Martha Grogan, Eli Muchtar, et al.
Haematologica
|
June 5, 2013
A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?
Nelson Leung, Siobhan V Glavey, Shaji Kumar, et al.
British Journal of Haematology
|
May 26, 2012
Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma
Alexandra J Greenberg, S Vincent Rajkumar, Dirk R Larson, et al.
Page
of 76
Search research articles
Search
Showing results (371-380 of 759) with videos related to
Sort By:
Page
of 76
Journal of the National Cancer Institute
|
April 5, 2014
Multiple myeloma in the very old: an IASIA conference report
Sascha A Tuchman, Gary R Shapiro, William B Ershler, et al.
Blood
|
October 19, 2007
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
Angela Dispenzieri, Robert A Kyle, Jerry A Katzmann, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
February 26, 2017
Cardiac MR elastography for quantitative assessment of elevated myocardial stiffness in cardiac amyloidosis
Arvin Arani, Shivaram P Arunachalam, Ian C Y Chang, et al.
Bone Marrow Transplantation
|
November 19, 2020
Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis
Iuliana Vaxman, M Hasib Sidiqi, Abdullah S Al Saleh, et al.
Leukemia
|
June 25, 2021
A randomized phase 3 study of ixazomib-dexamethasone versus physician's choice in relapsed or refractory AL amyloidosis
Angela Dispenzieri, Efstathios Kastritis, Ashutosh D Wechalekar, et al.
Human Pathology
|
October 16, 2025
Dual amyloidosis: A clinicopathologic and proteomic analysis of 111 patients
Joanna C Dalland, Surendra Dasari, Jason D Theis, et al.
Blood Cancer Journal
|
May 13, 2020
Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)
Brian G M Durie, Antje Hoering, Rachael Sexton, et al.
ESC Heart Failure
|
August 31, 2024
Predictors of mortality by an artificial intelligence enhanced electrocardiogram model for cardiac amyloidosis
Jennifer M Amadio, Martha Grogan, Eli Muchtar, et al.
Haematologica
|
June 5, 2013
A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?
Nelson Leung, Siobhan V Glavey, Shaji Kumar, et al.
British Journal of Haematology
|
May 26, 2012
Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma
Alexandra J Greenberg, S Vincent Rajkumar, Dirk R Larson, et al.
Page
of 76